Dr. Erika P Hamilton
Claim this profileSarah Cannon Research Institute
Expert in Breast Cancer
Expert in Ovarian Cancer
53 reported clinical trials
76 drugs studied
About Erika P Hamilton
Education:
- Obtained MD from the University of Tennessee Health Science Center, Memphis, TN.
- Completed Residency in Internal Medicine at Vanderbilt University Medical Center, Nashville, TN.
- Undertook Fellowship in Hematology/Oncology at Vanderbilt University Medical Center, Nashville, TN.
Experience:
- Currently serves as the Director of Breast Cancer and Gynecologic Cancer Research at Sarah Cannon Research Institute.
- Specializes in the treatment of breast cancer and gynecologic malignancies.
Area of expertise
1Breast Cancer
Global LeaderStage IV
HER2 negative
Stage III
2Ovarian Cancer
Global LeaderStage IV
FRα positive
ER positive
Affiliated Hospitals
Clinical Trials Erika P Hamilton is currently running
CLN-619 + Pembrolizumab
for Cancer
This trial is testing a new drug called CLN-619 alone and with pembrolizumab in patients with advanced solid tumors. These patients may not have other treatment options. Pembrolizumab helps the immune system fight cancer, and they are seeing if CLN-619 can help too.
Recruiting1 award Phase 110 criteria
Tucatinib + Doxil
for Breast Cancer
This clinical trial is evaluating tucatinib in combination with Doxil in participants with human epidermal growth factor 2 positive (HER2+) locally advanced or metastatic breast cancer. The main goals of this study are to: * Learn how well the combination of tucatinib and Doxil works * Learn more about the side effects of the combination of tucatinib and Doxil
Recruiting1 award Phase 213 criteria
More about Erika P Hamilton
Clinical Trial Related4 years of experience running clinical trials · Led 53 trials as a Principal Investigator · 14 Active Clinical TrialsTreatments Erika P Hamilton has experience with
- Tucatinib
- Fulvestrant
- Trastuzumab
- Abemaciclib
- Placebo
- Paclitaxel
Breakdown of trials Erika P Hamilton has run
Breast Cancer
Ovarian Cancer
Ovarian Tumors
Fallopian Tube Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Erika P Hamilton specialize in?
Erika P Hamilton focuses on Breast Cancer and Ovarian Cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are HER2 negative.
Is Erika P Hamilton currently recruiting for clinical trials?
Yes, Erika P Hamilton is currently recruiting for 14 clinical trials in Nashville Tennessee. If you're interested in participating, you should apply.
Are there any treatments that Erika P Hamilton has studied deeply?
Yes, Erika P Hamilton has studied treatments such as Tucatinib, Fulvestrant, Trastuzumab.
What is the best way to schedule an appointment with Erika P Hamilton?
Apply for one of the trials that Erika P Hamilton is conducting.
What is the office address of Erika P Hamilton?
The office of Erika P Hamilton is located at: Sarah Cannon Research Institute, Nashville, Tennessee 37203-1625 United States. This is the address for their practice at the Sarah Cannon Research Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.